Serial changes in glucose-loaded 18F-fluoro-2-deoxyglucose positron emission tomography, 99 mTc-tetrofosmin and 123I-beta-methyl-p-iodophenyl-penta-decanoic acid myocardial single-photon emission computed tomography images in patients with anterior acute myocardial infarction

Circulation Journal

Volumn 77, Issue 1, 2013, Pages 137-145

  Fukuoka, Ryota ^a   Horita, Yuki ^a   Namura, Masanobu ^a   Ikeda, Masatoshi ^a   Terai, Hidenobu ^a   Tama, Naoto ^a   Takagi, Toshimitsu ^a   Bunko, Hisashi ^a  

^a KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Glucose loaded 18F FDG PET; Myocardial viability; Percutaneous coronary intervention

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IODOFILTIC ACID I 123; TETROFOSMIN TC 99M;

ADULT; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHANTOM; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; FATTY ACIDS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PERCUTANEOUS CORONARY INTERVENTION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84871675266     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0011     Document Type: Article

References (37)

1. Depre C, Vanoverschelde J, Taegtmeyer H. Glucose for heart. Circulation 1999; 99: 578-588.
2. Taegtmeyer H. Energy metabolism of the heart: From basics concepts to clinical application. Curr Probl Cardiol 1994; 19: 60-113.
3. Neely JR, Revetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-329.
4. Opie LH, Qwen P, Riemersma RA. Relative rates of oxidation of glucose and free fatty acids by ischemic and non-ischemic myocardium after coronary artery ligation in the dog. Eur J Clin Invest 1973; 3: 419-435.
5. Auerbach MA, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999; 99: 2921-2926.
6. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993; 22: 984-997.
7. Di carli MF, Division M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
8. Eitzman D, al-Aouar Z, Kanter HL, Vom Dahl J, Kirsh M, Deeb GM, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J AM Coll Cardiol 1992; 20: 559-565.
9. Ammirati E, Rimoldi OE, Camici PG. Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction? Circ J 2011; 75: 3-10.
10. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on progonosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J AM Coll Cardiol 2002; 39: 1151-1158.
11. Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R, et al. Prediction of reversible ischemia after revascularization: Perfusion and metabolic studies with positron emission tomography. Circulation 1995; 91: 1697-1705.
12. Gropler RJ. Imaging to distinguish between viable and nonviable myocardium: Pathophysiologic basis and importance of positron emission tomography. Am J Roentgenol 1993; 161: 497-500.
13. Yoshinaga K, Manabe O, Tamaki N. Physiological assessment of myocardial perfusion using nuclear cardiology would enhance coronary artery disease patient care: Which imaging modality is best for evaluation of myocardial ischemia? (SPECT-side) Circ J 2011; 75: 713-722.
14. Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesion in the pancreas. Cancer 2000; 89: 2547-2554.
15. Takeuchi H, Kashiwagi H, Fujita H, Kondo A, Okada S. A case of splenic inflammatory pseudotumor with high FDG accumulation on FDG-PET. Jpn J Gastroenterol Surg 2008; 41: 218-223.
16. Nonogi, H, Miyazaki S, Goto Y, Ishida Y, Uehara T, Nishimura T. Efficacy and limitation of F-18-fluorodeoxy-glucose positron emission tomography during fasting to assess myocardial viability in the acute phase of myocardial infarction. J Intern Med 1998; 37: 653-661.
17. Seki H, Toyama T, Higuchi K, Kasama S, Ueda T, Seki R, et al. Prediction of functional improvement of ischemic myocardium with 123I-BMIPP SPECT and 99 mTc-Tetrofosmin SPECT imaging: A study of patients with large acute myocardial infarction and receiving revascularization therapy. Circ J 2005; 69: 311-319.
18. Bacharach SL, Bax JJ, Case J, Delbeke D, Kurdziel KA, Martin WH, et al. PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for patient preparation and data acquisition. J Nucl Cardiol 2003; 10: 543-556.
19. Cerqueira MD. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002; 9: 240-245.
20. Garcia EV, Train KV, Maddahi J, Prigent F, Friedman J, Areeda J, et al. Quantification of rotational Thallium-201 myocardial tomography. J Nucl Med 1985; 26: 17-26.
21. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021-1031.
22. Schwaiger M, Brunken R, Grover-McKay M, Kurivokapich J, Child J, Tillisch JH, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986; 8: 800-808.
23. Schelbert HR, Beanlands R, Bengel F, Knuuti J, Dicarli M, Machac J, et al. PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting. J Nucl Cardiol 2003; 10: 557-571.
24. Maes A, Van de Welf F, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis: Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995; 92: 2072-2078.
25. Maes A, Mortelmans L, Nuyts J, Bormans G, Herregods MC, Bijnens B, et al. Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute myocardial infarction. Eur Heart J 1997; 18: 954-962.
26. Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Takeuchi K, Yoshikawa J, et al. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999; 40: 1492-1498.
27. Shirasaki H, Nakano A, Uzui H, Yonekura Y, Okazawa H, Ueda T, et al. Comparative assessment of 18F-fluoro-deoxyglucose PET and 99 mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction. Eur J Nucl Med Mol Imaging 2006; 33: 879-886.
28. Myears DW, Sobel BE, Bergmann SR. Substrate use in ischemic and reperfused canine myocardium: Quantitative considerations. Am J Physiol 1998; 253: H107-H114.
29. Schwaiger M, Pirich C. Reverse flow-metabolism mismatch: What does it mean? J Nucl Med 1999; 40: 1499-1502.
30. Kanayama S, Satake O, Matsunari I, Fukuda A, Kitayama M, Asaji T, et al. Case report: Unstable angina with flow-fatty acid metabolism mismatch and reverse flow-glucose metabolism mismatch patterns. Ann Nucl Med 2003; 17: 699-702.
31. Mesotten L, Maes A, Herregods MC, Desmet W, Nuyts J, Van de Werf F, et al. PET "reversed mismatch pattern" early after acute myocardial infarction: Follow-up of flow, metabolism and function. Eur J Nucl Med 2001; 28: 466-471.
32. Beyersdorf F, Acar C, Buckberg GD, Partington MT, Sjöstrand F, Young HH, et al. Studies on prolonged acute regional ischemia. III: Early natural history of simulated single and multivessel disease with emphasis on remote myocardium. J Thorac Cardiovasc Surg 1989; 98: 368-380.
33. Godino C, Messa C, Gianolli L, Landoni C, Margonato A, Cera M, et al. Multifocal, persistent cardiac uptake of [18-F]-fluoro-deoxyglucose detected by positron emission tomography in patients with acute myocardial infarction. Circ J 2008; 72: 1821-1828.
34. 201Tl dual-isotope SPECT. Ann Nucl Med 2002; 16: 563-568.
35. International Commission on Radiological Protection (ICRP). Publication 106: Radiation dose to patients from radiopharmaceuticals: Addendum 3 to ICRP Publication 53. Ann ICRP 2008; 38: 1-197.
36. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation 2007; 116: 1290-1305.
37. Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härköne R, Ahonen A, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33: 1255-1262.